Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when RDZN files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRoadzen defers + in convertible note payments by 2-3 months, adds dilutive down-round protection
Filed May 22, 2026 · Period ending May 22, 2026 · ~1 min read
Key Changes
-
high
Company added down-round protection to November convertible note that automatically lowers conversion price if future equity is raised below current terms, potentially increasing shareholder dilution
Item 1.01 verify on EDGAR → -
high
Must seek shareholder vote to allow conversion of notes into shares exceeding 20% of outstanding stock, indicating substantial potential dilution from these debt instruments
Item 1.01 verify on EDGAR → -
medium
Deferred three installment payments totaling undisclosed amounts from April/May 2026 to July 20, 2026, suggesting near-term cash flow pressure requiring 2-3 month payment relief
Item 1.01 verify on EDGAR → -
medium
Eliminated requirement to use 25% of future financing proceeds to pay down November note, giving company more capital flexibility but extending potential dilution timeline
Item 1.01 verify on EDGAR → -
medium
Third amendment to securities purchase agreement executed, following two prior modifications to original convertible debt financing arrangement
Item 9.01 verify on EDGAR →
Summary
Roadzen amended its convertible debt agreements for the third time, pushing back multiple installment payments originally due in April and May 2026 to July 20, 2026. The deferrals suggest the company is managing near-term cash constraints and needed breathing room on debt obligations.
More significantly, the company added anti-dilution protection to its November note that will automatically lower the conversion price if Roadzen raises equity capital at unfavorable terms—a provision that could substantially increase dilution to existing shareholders.
The amendments also require Roadzen to seek shareholder approval for potential share issuances exceeding 20% of outstanding stock upon note conversion, a Nasdaq requirement that signals the magnitude of potential dilution. Meanwhile, the company removed its obligation to use 25% of future capital raises to pay down the November note, preserving financial flexibility but potentially extending the timeline for these convertible instruments to hang over the stock. Retail investors should watch for the upcoming shareholder vote on the conversion authorization and monitor whether the company successfully raises equity before July 20, 2026—and if so, at what price relative to the current conversion terms. Any equity raise below the conversion price would trigger the new anti-dilution mechanism and increase share count impact.
Section-by-Section Diff
Event · Item 1.01 — Entry into a Material Definitive Agreement
Roadzen amended convertible notes to defer installment payments from April/May 2026 to July 2026 and modify conversion terms.
Added in current filing · verify on EDGAR →
the Third Amendment amends the November Note to (i) change the dates on which the “Installment Amounts” otherwise due under the November Note on April 21, 2026 and May 21, 2026 are due to July 20, 2026
The company deferred two installment payments on its November 2025 convertible note from April 21, 2026 and May 21, 2026 to July 20, 2026. This represents a roughly 2-3 month extension on debt obligations that were originally due in the near term.
Added in current filing · verify on EDGAR →
The Third Amendment also (i) changes the date on which the “Installment Amount” otherwise due under the January Note on May 20, 2026 is due to July 20, 2026
The company also deferred an installment payment on its January 2026 convertible note from May 20, 2026 to July 20, 2026, a two-month extension. Combined with the November note deferrals, this suggests potential near-term cash flow constraints requiring payment relief.
Added in current filing · verify on EDGAR →
add a provision that would adjust the “Conversion Price” of the November Note in the event of certain equity financings below the Conversion Price then in effect, equivalent to the provision in the January Note
The November note now includes a down-round protection mechanism that adjusts the conversion price downward if the company raises equity at a lower price. This increases potential dilution to existing shareholders if future equity is raised at unfavorable terms.
Added in current filing · verify on EDGAR →
the Company is required to use commercially reasonable efforts to obtain the approval, for purposes of Nasdaq Listing Rules, of its shareholders to issue a number of the Company’s ordinary shares upon conversion of the November Note and the January Note in excess of 20% of the total number of ordinary shares outstanding as of November 20, 2025
The company must seek shareholder approval to issue shares exceeding 20% of shares outstanding upon note conversion, as required by Nasdaq rules. This indicates the potential dilution from these convertible notes is substantial and will require a shareholder vote.
Event · Item 9.01 — Financial Statements and Exhibits
Item 9.01 — Financial Statements and Exhibits filed; see Key Changes for terms.
Added in current filing · verify on EDGAR →
Third Amendment to Securities Purchase Agreement and Junior Convertible Notes, dated May 22, 2026.
Roadzen has entered into a third amendment to its existing securities purchase agreement and junior convertible notes. This represents the third modification to the original financing arrangement, though the 8-K does not disclose the specific terms, changes, or financial impact of this amendment. The amendment could involve changes to conversion terms, interest rates, maturity dates, or other material provisions of the convertible debt.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 24, 2026 · How we verify